Cephea South America Feasibility Study
NCT: NCT07244939 · ACTIVE_NOT_RECRUITING
광고
NCT IDNCT07244939
상태ACTIVE_NOT_RECRUITING
시작일2025-06-17
SponsorAbbott Medical Devices (INDUSTRY)
First posted
Last updated
간략 요약
The objective of this study is to evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral valve disease (including mitral regurgitation, mitral stenosis and mixed mitral valve disease) in whom transcatheter therapy is deemed more appropriate than open heart surgery.
공식 출처
ClinicalTrials.gov에서 보기 →데이터는 ClinicalTrials.gov API에서 제공됩니다. 최신 상태는 공식 기록을 확인하세요.